
Primary idiopathic seborrhea is a skin disease seen in dogs and rarely in cats. It is characterized by a defect in keratinization that results in increased scale formation, occasionally excessive greasiness of the skin and hair coat, and often secondary inflammation and infection. Primary seborrhea is not pruritic.
Secondary seborrhea, in which a primary underlying disease causes similar clinical signs, is more common than primary seborrhea. Secondary seborrhea may or may not be pruritic.
Seborrhea in horses is usually secondary to either pemphigus foliaceus or equine sarcoidosis Equine Sarcoids Equine sarcoids are the most commonly diagnosed tumor of equids, representing 20% of all equine neoplasms and 36% of all skin tumors in horses. Studies suggest there is no significant sex or... read more (chronic granulomatous disease).
Etiology, Clinical Findings, and Diagnosis of Seborrhea in Animals
Primary seborrhea is diagnosed by ruling out underlying causes of secondary seborrhea
Primary seborrhea is an inherited skin disorder characterized by faulty keratinization of the epidermis, hair follicle epithelium, or claws. It is seen more frequently in:
American Cocker Spaniels
English Springer Spaniels
Basset Hounds
West Highland White Terriers
Dachshunds
Labrador and Golden Retrievers
German Shepherds
There is usually a familial history of seborrhea, suggesting genetic factors. The disease begins at a young age (usually < 18–24 months) and typically progresses throughout the animal’s life. A diagnosis of generalized primary seborrhea should be reserved for cases in which all possible underlying causes have been excluded.
To diagnose primary seborrhea, the condition must be confirmed as not pruritic and the following tests performed:
skin scrapings to rule out demodicosis
superficial skin cytology to rule out bacterial and yeast dermatitis
blood testing to rule out endocrinopathies
If all of these tests are normal, a skin biopsy must be performed to confirm the diagnosis of primary seborrhea.
Most seborrheic animals have secondary seborrhea, in which a primary underlying disease predisposes to excessive scaling, crusting, or oiliness, often accompanied by superficial pyoderma, Malassezia (yeast) infection, and alopecia. The most common underlying causes are endocrinopathies and allergies. The goal is to identify and treat any underlying cause of the seborrhea. Palliative therapies that do not compromise the diagnostic evaluation should be instituted concurrently to provide as much immediate relief as possible.
Underlying diseases may present with seborrhea as the primary clinical problem. The signalment (age, breed, sex) and history may provide clues in diagnosing the underlying cause. Environmental allergies (atopic dermatitis) are more likely to be the underlying cause if age at onset is < 5 years, whereas an endocrinopathy or neoplasia (especially cutaneous lymphoma) is more likely if the seborrhea begins in middle-aged or older animals.
The degree of pruritus should also be noted. If pruritus is minimal, endocrinopathies, other internal diseases, or certain diseases limited to the skin (eg, demodicosis or sebaceous adenitis) should be excluded. If pruritus is significant, allergies and pruritic ectoparasitic diseases (eg, scabies, fleas) should be considered. The presence of pruritus does not exclude nonpruritic disease as the underlying cause, because the presence of a pyoderma, Malassezia infection, or inflammation from the excess scale can cause significant pruritus. However, a lack of pruritus helps to exclude allergies, scabies, and other pruritic diseases as the underlying cause.
Other important considerations include the presence of:
polyuria, polydipsia, or polyphagia
heat-seeking behavior
abnormal estrous cycles
pyoderma
seasonal variation in signs
responses to changes in diet
responses to previous medications (including corticosteroids, antibiotics, antifungals, antihistamines, or topical treatments)
risk of zoonosis or contagion
environmental influences
The duration and severity of disease as well as level of owner frustration are important factors in determining the aggressiveness of the diagnostic plan.
A thorough physical examination, including internal organ systems and a comprehensive dermatologic examination, is the first step in identifying the underlying cause. The dermatologic examination should document the type and distribution of the lesions; the presence of alopecia; and the degree of odor, scale, oiliness, and texture of the skin and hair coat. The presence of follicular papules, pustules, crusts, and epidermal collarettes usually indicates the existence of a superficial pyoderma. Hyperpigmentation indicates a chronic skin irritation (such as pruritus, infection, or inflammation), and lichenification indicates chronic pruritus. Yeast (Malassezia spp) infection should always be considered when evaluating a seborrheic animal.
Secondary infection plays a significant role in most cases of seborrhea. The sebum and keratinization abnormalities that are common in seborrhea frequently provide ideal conditions for bacterial and yeast infections. The self-trauma that occurs in pruritic animals increases the likelihood of a secondary infection. Often, coagulase-positiveStaphylococcus spp or Malassezia spp are present. The infections add to the pruritus and are usually responsible for a significant amount of the inflammation, papules, crusts, alopecia, and scales.
One of the first diagnostic steps is to obtain superficial cytology of the affected areas to identify the quantity and type of bacteria or yeast present. If numerous cocci and neutrophils are present, pyoderma is likely. In addition to systemic therapy, topical shampoos will aid in the treatment of secondary infections. In a seborrheic dog with pruritus, the infection may cause all or most of the pruritus. Instead of considering allergies as the underlying disease in these dogs, nonpruritic diseases (eg, endocrinopathies) may be uncovered by addressing the infections.
After the infections have been addressed, other diagnostic tests that should be considered include multiple deep skin scrapings, dermatophyte culture, impression smears, trichograms, and flea combing. If these are negative or normal, a skin biopsy, CBC, serum biochemical profile, and complete urinalysis will complete the minimum database. Examples of diagnostic clues include increased serum alkaline phosphatase (which may suggest hyperadrenocorticism or previous steroid therapy), cholesterol (which may suggest hypothyroidism), blood glucose (which suggests diabetes mellitus), and BUN or creatinine (which may suggest renal disease).
Treatment of Seborrhea in Animals
For primary seborrhea, treatment includes frequent bathing, along with Vitamin A or a retinoid
Treatment for primary idiopathic seborrhea involves bathing the dog 2–3 times per week until the desired effect has been achieved. Bathing 1–2 times per week is generally sufficient for maintenance. Shampoos containing chlorhexidine, climbazole, and phytosphingosine are often effective; however, if greasiness persists, a benzoyl peroxide or selenium sulfide shampoo can be tried. Systemic therapy with Vitamin A (10,000 IU PO once daily, maximum 800–1,000 IU/kg, PO, once daily) or synthetic retinoids (eg, isotretinoin or acitretinoin [1–2 mg/kg, PO, once daily, reducing to 1 mg/kg, PO, every two days, for maintenance]) can be instituted if topical therapy is not sufficient.
Treatment for secondary seborrhea is much more complex. For treatment of seborrhea with concurrent pyoderma, an antibiotic with known sensitivity against Staphylococcus pseudintermedius should be appropriate. Examples of such antibiotics are:
Clindamycin, 5.5–10 mg/kg, PO, twice daily
Lincomycin, 15–25 mg/kg, PO, twice daily
Cephalexin, 20–30 mg/kg, PO, twice daily
Amoxicillin-clavulanate, 12.5–25 mg/kg, PO, twice daily
Trimethoprim potentiated sulfonamide, 15–30 mg/kg, PO, twice daily
Because most staphylococcal infections in seborrhea cases are superficial pyodermas, they should be treated for a minimum of 4 weeks.
With the increase in methicillin-resistant S pseudintermedius, S aureus, and S schleiferi, it is strongly recommended to perform a bacterial culture of any animal with pyoderma that does not begin to respond to an antibiotic after 3–4 weeks. Epidermal collarettes may be cultured using a dry sterile culturette rolled across the collarettes. Although methicillin-resistant S pseudintermedius infections are more difficult to treat, they are not more virulent or visually striking than those due to methicillin-susceptible S pseudintermedius. Previous (ie, within the past year) hospitalization, surgery, or previous antibiotic treatment are all possible risk factors for development of methicillin-resistant S pseudintermedius infections.
Seborrhea with concurrent Malassezia dermatitis may be treated systemically with an azole such as ketoconazole or fluconazole (5 mg/kg/day for 4 weeks) or treated topically with an antifungal shampoo, foam, or spray.
In addition to addressing any secondary infections, antipruritic therapy and shampoo therapy are usually needed to help control the seborrhea and speed the return of the skin to a normal state. Shampoo therapy can decrease the number of bacteria and yeast on the skin surface, the amount of scale and sebum present, and the level of pruritus; it also helps normalize the epidermal turnover rate.
Most active ingredients contained in shampoos can be classified based on their effects as keratolytic, keratoplastic, emollient, antipruritic, or antimicrobial. Keratolytic products include sulfur, salicylic acid, tar, selenium sulfide, propylene glycol, fatty acids, and benzoyl peroxide. They remove stratum corneum cells by causing cellular damage that results in ballooning and sloughing of the surface keratinocytes. This reduces the scale and makes the skin feel softer. Shampoos containing keratolytic products frequently exacerbate scaling during the first 14 days of treatment because the sloughed scales get caught in the hair coat. The scales will be removed by continued bathing, but owners should be warned that the scaling often worsens initially.
Keratoplastic products help normalize keratinization and reduce scale formation by slowing down epidermal basal cell mitosis. Tar, sulfur, salicylic acid, and selenium sulfide are examples of keratoplastic agents.
Emollients (eg, lactic acid, sodium lactate, lanolin, and numerous oils, such as corn, coconut, peanut, and cottonseed) are indicated for any scaling dermatosis, because they reduce transepidermal water loss. They are most effective after the skin has been rehydrated and are excellent adjunct products after shampooing.
Antibacterial agents include benzoyl peroxide, chlorhexidine, ethyl lactate, tris-EDTA, and triclosan.
Antifungal ingredients include chlorhexidine, sulfur, ketoconazole, and miconazole. Boric and acetic acids are also used as topical antimicrobials.
It is important to know how individual shampoo ingredients act, as well as any additive or synergistic effects they have, because most shampoos are a combination of products. The selection of appropriate antiseborrheic shampoo therapy is based on hair coat and skin scaling and oiliness, of which there are four general presentations:
mild scaling and no oiliness
moderate to marked scaling and mild oiliness (the most common)
moderate to marked scaling and moderate oiliness
mild scaling and marked oiliness
These categories are intended to guide the type of shampoo therapy necessary; however, all factors for each individual animal should be considered.
Animals with mild scaling and no oiliness need mild shampoos that are gentle, cleansing, hypoallergenic, or moisturizing. These shampoos are indicated for animals that have mild seborrheic changes, are irritated by medicated shampoos, or bathed too often. These products often contain emollient oils, lanolin, lactic acid, urea, glycerin, or fatty acids. Emollient sprays or rinses are often used in conjunction with these shampoos.
Animals with moderate to marked scaling and mild to marked oiliness should be bathed with shampoos that contain sulfur and salicylic acid. Both agents are keratolytic, keratoplastic, antibacterial, and antipruritic. In addition, sulfur is antiparasitic and antifungal. Some of these shampoos also contain ingredients that are antibacterial, antifungal, and moisturizing, which can help control secondary pyoderma, Malassezia spp, and excessive scaling. Shampoos that contain ethyl lactate lower the cutaneous pH (which has a bacteriostatic or bactericidal action by inhibiting bacterial lipases), normalize keratinization, solubilize fats, and decrease sebaceous secretions. These actions also result in potent antibacterial activity.
In the past, dogs with moderate to severe scaling and moderate oiliness were often treated with tar-containing shampoos. However, because tar shampoos usually have an unpleasant odor and can be irritating, along with poor owner compliance, they usually are no longer recommended.
In animals with severe oiliness and minimal scaling, profound odor, erythema, inflammation, and a secondary generalized pyoderma or Malassezia dermatitis are often present. Shampoos that contain benzoyl peroxide provide strong degreasing actions along with potent antibacterial and follicular flushing activities. Because benzoyl peroxide shampoos are such strong degreasing agents, they can be irritating and drying. Other antibacterial shampoos are better suited in animals that have superficial pyoderma without significant oiliness. These shampoos usually contain 2%–4% chlorhexidine (often in association with tris-EDTA) or ethyl lactate. The follicular flushing action of benzoyl peroxide makes it helpful for animals with numerous comedones or with demodicosis. Benzoyl peroxide gels (5%) are good choices when antibacterial, degreasing, or follicular flushing actions are desired for focal areas, such as in localized demodicosis, canine acne, or Schnauzer comedone syndrome. However, these gels also may be irritating.
Key Points
Primary seborrhea is rare, but secondary seborrhea is common.
Primary seborrhea is not pruritic.
Primary seborrhea cannot be not cured but can be controlled with continuous therapy.